Get the Stockscreener App
0.3563
1.57%
-0.0057
After Hours:
.36
0.0037
+1.04%
Klotho Neurosciences Inc stock is traded at $0.3563, with a volume of 62,073.
It is down -1.57% in the last 24 hours and down -27.60% over the past month.
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
See More
Previous Close:
$0.362
Open:
$0.35
24h Volume:
62,073
Relative Volume:
0.08
Market Cap:
$9.61M
Revenue:
-
Net Income/Loss:
$-4.23M
P/E Ratio:
-1.6902
EPS:
-0.2108
Net Cash Flow:
-
1W Performance:
-6.24%
1M Performance:
-27.60%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.34
$0.3684
1-Week Range:
$0.34
$0.41
52-Week Range:
$0.26
$0.9473
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
646-916-5315
Address
1115 BROADWAY, NEW YORK
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.3563 | 9.61M | 0 | -4.23M | 0 | -0.2108 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.23 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Klotho Neurosciences secures $2M in convertible notes and warrants By Investing.com - Investing.com Canada
Klotho Neurosciences secures $2M in convertible notes and warrants - Investing.com
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - The Manila Times
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences secures $1.2 million convertible note By Investing.com - Investing.com Canada
Klotho Neurosciences secures $1.2 million convertible note - Investing.com India
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts - GlobeNewswire
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board - Yahoo Finance
Former Merck USA President Joins Klotho Neurosciences' Board of Directors - The Manila Times
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors - GlobeNewswire
Klotho Neurosciences Taps Former Merck US President Who Led $12B Portfolio to Board of Directors - StockTitan
Klotho Neurosciences expands Board with seasoned healthcare executive By Investing.com - Investing.com Canada
Klotho Neurosciences expands Board with seasoned healthcare executive - Investing.com
Klotho Neurosciences, Inc. and Teleost Biopharmaceuticals, LLC Terminate Licensing Agreement - Marketscreener.com
Klotho Neurosciences Inc. (KLTO) reports earnings - Quartzy
Klotho Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Klotho Neurosciences Ends Licensing Agreement with Teleost - TipRanks
Klotho Neurosciences CEO secures new three-year contract By Investing.com - Investing.com Australia
KLTO stock touches 52-week low at $0.39 amid market challenges - Investing.com
Klotho Neurosciences announces accounting firm change - Investing.com India
Klotho Neurosciences CEO secures new three-year contract - Investing.com India
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor - GlobeNewswire
Klotho Neurosciences faces Nasdaq delisting over share price - Investing.com India
Klotho Neurosciences faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences - GlobeNewswire
Maravai Lifesciences (MRVI) Stock Surges Over 5% Amid Strong Buy Recommendations - GuruFocus.com
Wall Street today: Nasdaq drops 0.24% amid Middle Eastern crisis, oil price spike; Tesla sinks 4% | Stock Market News - Mint
Medallion Bank Announces Fintech Strategic Partnership With Kashable - The Manila Times
Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO) - GlobeNewswire Inc.
Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO) - GlobeNewswire
Dr. Robert Langer Joins Scientific Advisory Board of Klotho Neurosciences - citybiz
KLTOKlotho Neurosciences, Inc. Latest Stock News & Market Updates - StockTitan
XPPen Announces Participation at PAX AUS, Teasing the Unveiling of Groundbreaking Drawing Displays - The Manila Times
Retail investors in Eagers Automotive Limited (ASX:APE) are its biggest bettors, and their bets paid off as stock gained 3.3% last week - Yahoo Finance UK
UK business confidence falls from eight-year high, Lloyds says - Yahoo Finance UK
Britain to become first G7 country to end coal power as last plant closes - Yahoo Finance UK
The Apprentice winner Dr Leah Totton sells Lord Sugar-backed cosmetics clinics - Yahoo Finance UK
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN - ForexTV.com
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Klotho Neurosciences Inc Stock (KLTO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| CHARDAN CAPITAL MARKETS LLC | 10% Owner |
Jul 01 '24 |
Sale |
2.06 |
115,136 |
237,618 |
1,464,364 |
| CHARDAN CAPITAL MARKETS LLC | 10% Owner |
Jun 28 '24 |
Sale |
2.53 |
47,000 |
119,103 |
1,579,500 |
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):